The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...
Indies Pharma secures $60 million from first batch of FDA-approved drug
PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...
Trump's tariffs, trade war with China could worsen prescription drug shortages in US
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...
GLP-1 drugs could become tougher to get. 3 cheap supplements that can aid weight loss
Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...
Becker's Hospital Review2d
FDA finds cleaning, testing issues at drug plant linked to 8 deaths
The FDA found concerns at a factory in India that makes generic drugs for U.S. patients including one drug that was manufactured at the facility and has been linked to at least eight deaths, ...
BioPharma Dive4d
Bioequivalence studies: the key to a successful new generic
A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...
The Healthy @Reader's Digest on MSN9d
Almost 37,000 Bottles of a Popular Anxiety and Depression Drug Recalled Nationwide
It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...
Tariffs could strain the already tight supply of prescription drugs, leading to drug shortages
A 20% tariff on Chinese imports could drive up the cost of generic prescription drugs, which could impact pharmacies and ...
Cheaper, generic versions of Ozempic could come to Canada as early as next year
Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...
Crain's Chicago Business2d
Maia Bio touts two advances for its lead cancer drug in development
THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...